A histological study of the structural changes in the liver of streptozotocin-induced diabetic rats treated with or without Momordica charantia (bitter gourd)

Clinica Terapeutica

Volumn 160, Issue 4, 2009, Pages 283-286

  Teoh, S L ^a   Latiff, A A ^a   Das, Srijit ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Bitter gourd; Diabetes; Histology; Liver; Momordica charantia

Indexed keywords

GLYCOSAMINOGLYCAN; MOMORDICA CHARANTIA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HISTOPATHOLOGY; INFLAMMATION; LIVER; LIVER CELL; LIVER FUNCTION; LIVER INJURY; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; LIVER; MALE; MOMORDICA CHARANTIA; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70349383219     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053
2. WHO. World Health Statistics 2008. Geneva, World Health Organization, 2008
3. Liu IM, Chang CK, Juang SW, et al. Role of hyperglycaemia in the pathogenesis of hypotension observed in type-1 diabetic rats. Int J Exp Path 2008; 89:292-300
4. Yadav UC, Moorthy K, Baquer NZ. Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes in alloxan diabetic rats. Mol Cell Biochem 2005; 268:111-120
5. Subratty AH, Gurib-Hakim A, Mahomoodally F. Bitter melon: an exotic vegetable with medicinal values. Nutrition & Food Science 2005; 35:143-147
6. Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol 2004; 93:123-132
7. Lenzen S. The mechanism of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008; 51:216-226
8. Singh J, Adeghate E, Cummings E, et al. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin- induced diabetes mellitus in rat. Mol Cell Biochem 2004; 261:63-70
9. Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med 2005; 22:359-370
10. Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken) 2008; 291:684-92
11. McCuskey RS, Ito Y, Robertson GR, et al. Hepatic microcirculation dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 2004; 40:386-393
12. Semiz A, Sen A. Antioxidant and chemoprotective properties of Momordica charantia L. (bitter melon) fruit extract. African J Biotechnology 2007; 6:273-277
13. Wu SJ, Ng LT. Antioxidant and free radical scavenging activities of wild bitter melon (Momordica charantia Linn, var. abbreviata Ser.) in Taiwan. LWT - Food Science and Technology 2007; doi:10.1016/j.lwt.2007.03.003